[Plastic surgery for the treatment of gynaecomastia following hormone therapy in prostate carcinoma].
Gynecomastia is a potential side effect of hormone therapy for prostate cancer. In large, randomized, placebo controlled studies approximately 50% or more of patients with prostate cancer experienced gynecomastia attributable to various mechanisms. Although it is mostly reported as mild to moderate, gynecomastia is one of the reasons most frequently cited for premature discontinuation of such treatment. Prophylactic radiotherapy and prophylactic tamoxifen have been shown to decrease the incidence of hormone-induced gynecomastia; nevertheless, there are still cases of refractory gynecomastia, and in these plastic surgery is needed for correction. Gynecomastia is a benign enlargement of the male breast, requiring no treatment unless it is a source of embarrassment and/or distress for the adolescent or man affected. The indications for surgical treatment of gynecomastia are founded on two main objectives: restoration of the male chest shape and diagnostic evaluation of suspected breast lesions. The authors believe that the complete circumareolar technique with no further scarring creates the best aesthetic results with fewer complications. When this is used in combination with liposuction very pleasing aesthetic results can be achieved.
Ryssel
H
H
Klinik für Hand-, Plastische und Rekonstruktive Chirurgie - Schwerbrandverletztenzentrum, Plastische und Handchirurgie an der Universität Heidelberg, Ludwigshafen, Deutschland. hryssel@bgu-ludwigshafen.de
Germann
G
G
Köllensperger
E
E
Riedel
K
K
D000728:Androgens / Q000097:blood; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D004954:Esthetics; D004967:Estrogens / Q000097:blood; D006177:Gynecomastia / Q000097:blood / Q000139:chemically induced* / Q000601:surgery; D006801:Humans; D015187:Lipectomy / Q000379:methods; D008297:Male; D016462:Mammaplasty / Q000379:methods*; D015414:Mastectomy, Subcutaneous / Q000379:methods; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*
D000728:Androgens; D018931:Antineoplastic Agents, Hormonal; D004967:Estrogens